← Eichor
Study identifier: NCT07288983 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

PENG Block vs Suprainguinal FICB vs Lumbar ESPB for Analgesia After Hip Surgery

Condition: Hip Osteoarthritis  ·  Sponsor: Poznan University of Medical Sciences

PhaseNA
Planned participants93
Who can joinAll sexes, 65 Years to 100 Years
Healthy volunteersNo

About this study

This randomized, double-blinded, controlled clinical trial compares three motor-sparing regional anesthesia techniques used for postoperative analgesia in patients undergoing hip arthroplasty: the Pericapsular Nerve Group (PENG) block, the suprainguinal Fascia Iliaca Compartment Block (S-FICB), and the Lumbar Erector Spinae Plane Block (L-ESPB). Although all three techniques are widely used in modern hip surgery, their relative analgesic efficacy, opioid-sparing potential, and impact on early functional recovery have not been directly compared in a single study. The primary objective is to determine which block provides the most effective postoperative analgesia while preserving motor function and facilitating early mobilization. Secondary objectives include comparisons of opioid consumption, pain scores at rest and during movement, time to first rescue analgesia, block-related adverse events, quadriceps strength, incidence of postoperative nausea and vomiting, and early functional outcomes. This study aims to identify the optimal motor-sparing regional anesthesia strategy for older adults undergoing hip arthroplasty.

This description comes directly from the study's public registry record.

Talk to the study team

Malgorzata Reysner, MD PhD  ·  +48 61 873 83 03  ·  mreysner@ump.edu.pl

Always discuss trial participation with your own doctor first.

Locations (1)

Poznan University of Medical SciencesPoznan, PolandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07288983